Patient‐Reported Factors Influencing Clinical Trial Participation: An In‐depth Analysis of Patients With Lupus and Rheumatoid Arthritis
Systemic lupus erythematosus (SLE), a chronic systemic autoimmune disease, has only three approved therapies, despite a rapidly expanding number of clinical trials. Trials in SLE struggle to recruit patients and fail to fully enroll. Rheumatoid arthritis (RA), another chronic autoimmune disease, has...
Saved in:
| Main Authors: | Aliza Bloostein, Roberto Caricchio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | ACR Open Rheumatology |
| Online Access: | https://doi.org/10.1002/acr2.70035 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of Rheumatoid Factors on the Efficacy of TNF Inhibitor Therapy in Patients with Rheumatoid Arthritis
by: Atsushi Nagayasu, et al.
Published: (2025-05-01) -
CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01) -
T-regulatory cells in systemic lupus erythematosus and rheumatoid arthritis
by: A V Torgashina, et al.
Published: (2009-06-01) -
INFLIXIMAB-INDUCED LUPUS-LIKE SYNDROME IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS (A CASE REPORT): AN ACCIDENT OR REGULARITY?
by: Yu. V. Muravyev, et al.
Published: (2017-09-01) -
Study of Clinical and Epidemiological Factors in Patients Diagnosed with Rheumatoid Arthritis
by: Rolando Rodríguez Puga, et al.
Published: (2023-11-01)